Thrivent Financial for Lutherans’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-18,690	Closed	-$256K	–	2311
2020 Q1	$256K	Buy	+18,690	New	+$256K	﹤0.01%	2045